tiprankstipranks
NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
PremiumPress ReleasesNeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
26d ago
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
PremiumPress Releases
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
1M ago
Neuronetics announces 5-year exclusive partnership with TCN
PremiumThe Fly
Neuronetics announces 5-year exclusive partnership with TCN
1M ago
Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
PremiumPress ReleasesNeuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results
2M ago
Is STIM a Buy, Before Earnings?
PremiumPre-Earnings
Is STIM a Buy, Before Earnings?
2M ago
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
PremiumPress Releases
Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call
2M ago
Neuronetics sees 2023 revenue over $71M, consensus $70.77M.
PremiumThe FlyNeuronetics sees 2023 revenue over $71M, consensus $70.77M.
3M ago
Neuronetics sees Q4 revenue over $20M, consensus $19.76M
PremiumThe Fly
Neuronetics sees Q4 revenue over $20M, consensus $19.76M
3M ago
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
PremiumPress Releases
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100